Availability Of Pharmaceutical Products Within The N.h.s.

EDM number 1550 in 1993-94, proposed by Nicholas Winterton on 19/07/1994.

That this House welcomes the tremendous improvements in patient care brought about by innovative developments in the range, quality and effectiveness of pharmaceutical products available to patients; acknowledges the great contribution to the British economy of the pharmaceutical industry; commends United Kingdom pharmaceutical companies on their longstanding tradition of research and development at facilities of international standing in this country; believes that any threat to the stability and viability of this important industry would be a blow to patients, to the economy, and to the United Kingdom's international reputation for excellence; would oppose the introduction of any system which would further restrict the clinical and prescribing freedom of hospital doctors and general practitioners; and in particular rejects the suggestion that only those products included in a limited list of mandatory national formulary would remain reimbursable within the National Health Service.

This motion has been signed by a total of 22 MPs.